Manipal to buy TTK stake in Cigna

₹500-cr. transaction to help raise Manipal Group’s stake in JV to 51%, from 19.5%

June 04, 2019 08:46 pm | Updated 08:46 pm IST - Bengaluru

TTK Group has decided to exit from the Cigna TTK health insurance joint venture (JV) by selling its 31.5% stake to Manipal Group for ₹500 crore.

Manipal Education & Medical Group (MEMG) chairman Ranjan Pai told The Hindu that his company would increase its holding in the JV to 51% from the existing 19.5% at a cost of ₹500 crore. The Cigna Corporation of the U.S. will continue to hold 49% stake.

“We are buying the stake from TTK Group as they are exiting. However, all these, except the name change of the joint venture , are subject to further approvals from the regulator.” With TTK’s exit, the name of the JV has been changed to ManipalCigna Health Insurance Company Limited.

The venture has also adopted a new corporate identity, a new logo and a new website. These changes are effective immediately and all future business activities will be under the new company name.

Dr. Pai said: “Our aim is to become the third-largest standalone health insurance player in the country in the next couple of years.”

Star Health Insurance, Apollo Munich, Religare and MaxBupa are the leading standalone health insurance players in the country.

High-growth sector

Health insurance is a high-growth sector in the country, growing at a compounded annual growth rate of 26%. Medical inflation has been high with disease burden seeing a steady rise in the country.

“Despite all these, the country is underinsured. However, people are slowly realising the importance of having a safety net when it comes to health,” he added.

The Indian insurance sector had ‘tremendous’ growth potential and was an important market for Cigna Corporation, said Jason Sadler, president, Cigna International Markets.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.